CervoMed, Inc. (CRVO)
8.26
+0.07
(+0.85%)
USD |
NASDAQ |
Dec 12, 14:38
CervoMed EPS Diluted (Quarterly): -0.8351 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lexicon Pharmaceuticals, Inc. | -0.0351 |
| AIM ImmunoTech, Inc. | -1.569 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.727M |
| Revenue (Quarterly) | 0.3226M |
| Total Expenses (Quarterly) | 8.049M |
| Enterprise Value | 48.49M |
| Profit Margin (Quarterly) | -2.40K% |
| Earnings Yield | -35.05% |
| Normalized Earnings Yield | -35.05 |